The first optogenetic "Chimeric Rhodopsin" gene therapy tested in humans. RV-001 starting dose was generally well tolerated in this open-label trial.

GUANGZHOU,China,Feb. 13,2025-- As China\'s No.1 platform for international trade,the 137th Canton Fair has successfully hosted a Southeast Asiaroadshow with trade promotion events in Vietnam,Laos and

Landmark Collaboration Redefines Enterprise Data Management and Unleashes the Full Potential of Agentic AI

BEIJING,Feb. 13,2025--Gaotu Techedu Inc. ("Gaotu" or the "Company") (NYSE: GOTU),a technology-driven education company and online large-class tutoring service provider in China,tod

SINGAPORE,Feb. 13,2025-- Mega Matrix Inc. (NYSE American: MPU)\'s globally leading short series streaming platform,FlexTV,has launched a romantic miniseries exploring love,responsibility,and redempti

BANGKOK,Feb. 13,2025-- During a meeting with Thailand\'s Prime Minister,Ms.Paetongtarn Shinawatra,in Bangkok today,Mr. Masahiro Moro,President and CEO of Mazda Motor Corporation announced that the com